HemaCare Corporation
Net Income per Common and Common Equivalent Share
|
| Three Months Ended |
| Nine Months Ended |
| ||||||||
|
| September 30, |
| September 30, |
| ||||||||
|
| 2005 |
| 2004 |
| 2005 |
| 2004 |
| ||||
BASIC |
|
|
|
|
|
|
|
|
| ||||
Weighted average common shares used to compute basic earnings per share |
| 8,167,000 |
| 7,796,000 |
| 8,116,000 |
| 7,769,000 |
| ||||
Net income |
| $ | 295,000 |
| $ | 475,000 |
| $ | 1,011,000 |
| $ | 1,209,000 |
|
Basic net income per share |
| 0.04 |
| 0.06 |
| 0.12 |
| 0.16 |
| ||||
DILUTED |
|
|
|
|
|
|
|
|
| ||||
Weighted average common shares used to compute basic earnings per share |
| 8,167,000 |
| 7,796,000 |
| 8,116,000 |
| 7,769,000 |
| ||||
Dilutive common equivalent shares attributable to stock options (based on average market price) |
| 590,000 |
| 375,000 |
| 575,000 |
| 251,000 |
| ||||
Dilutive common equivalent shares attributable to warrants (based on average market price) |
| 152,000 |
| 84,000 |
| 150,000 |
| 57,000 |
| ||||
Weighted average common shares used to compute diluted earnings per share |
| 8,909,000 |
| 8,255,000 |
| 8,841,000 |
| 8,077,000 |
| ||||
Net income |
| $ | 295,000 |
| $ | 475,000 |
| $ | 1,011,000 |
| $ | 1,209,000 |
|
Dilutive net income per share |
| 0.03 |
| 0.06 |
| 0.11 |
| 0.15 |
|